| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.85B | -10.4% | +23.6% |
| R&D Expense | $67.4M | +6.3% | +41.9% |
| SG&A Expense | $40.1M | +20.4% | +46.4% |
| Operating Income | -$7.2M | -118.3% | -111.8% |
| Pre-tax Income | -$7.8M | -120.6% | -188.9% |
| Income Tax | -$200K | -166.7% | +33.3% |
| Net Income | -$4.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $170.3M | -3.9% | -19.4% |
| Accounts Receivable | $70.5M | -27.2% | +53.9% |
| Current Assets | $313.3M | -10.1% | -5.2% |
| Total Assets | $1.55B | -2.7% | +29.5% |
| Current Liabilities | $391.0M | -17.5% | +9.1% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $171.4M | — | — |
| Capital Expenditures | $10.3M | — | — |
| Investing Cash Flow | -$189.0M | — | — |
| Financing Cash Flow | -$35.9M | — | — |
| Free Cash Flow | $161.1M | — | — |
| -111.7% |
| -170.6% |
| EPS (Basic) | -$0.01 | -114.3% | — |
| EPS (Diluted) | -$0.01 | -114.3% | — |
| $775.1M |
| -11.0% |
| +0.8% |
| Stockholders' Equity | $773.3M | +7.4% | +80.7% |